QuickLinks -- Click here to rapidly navigate through this document

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549


FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): November 11, 2003

TRANSGENOMIC, INC.
(Exact name of registrant as specified in its charter)

Delaware   000-30975
(State of Formation)   (Commission File Number)

911789357
(IRS Employer Identification Number)

12325 Emmet Street
Omaha, NE

 

68164
(Address of principal executive offices)   (Zip Code)

(402) 452-5400
(Registrants' telephone number, including area code)

Not applicable
(Former name or former address, if changed since last report)





Item 7.    Financial Statements and Exhibits.


Item 12.    Results of Operations and Financial Condition.

        On November 11, 2003, Transgenomic, Inc. (the "Company") issued a press release announcing results of operations and summary financial position for the quarter and year-to-date periods ended September 30, 2003. The Company is attaching the press release as Exhibit 99.1 to this Current Report on Form 8-K.

2




SIGNATURE

        Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

    TRANSGENOMIC, INC.

 

 

By

/s/  
MICHAEL J. DRAPER      
Michael J. Draper, Chief Financial Officer

November 18, 2003

3





QuickLinks

SIGNATURE